This fund was established in 1996 by the Viola S. Rhodes Trust to support research in the cause and cure of myasthenia gravis.

Myasthenia gravis is an auto-immune disease in which antibodies are directed against the acetyl choline receptor on the muscle end-plate of the neuromuscular junction. These antibodies block or degrade the receptor, resulting in failure of neuromuscular transmission and weakness.